ADRX
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. insider trading
Insiders at ADARx Pharmaceuticals, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was George Simeon (Director · 10% Owner) buying $10.1M of ADRX, filed Sep 29, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $87.7M
- Sold
- —
- Insiders
- 5
- Latest trade
- Sep 28, 2026
From SEC filings · last 30 days
Recent ADRX insider transactions
Gordon Carl LDirector · 10% Owner
Bought 588,235 sh at $17.00 · Sep 28, 2026
$10M
FilingOrbimed Advisors LLCDirector · 10% Owner
Bought 588,235 sh at $17.00 · Sep 28, 2026
$10M
FilingOrbimed Advisors LLCDirector · 10% Owner
Bought 300,249 sh at $17.00 · Sep 28, 2026
$5.1M
FilingGordon Carl LDirector · 10% Owner
Bought 300,249 sh at $17.00 · Sep 28, 2026
$5.1M
FilingOrbimed Advisors LLCDirector · 10% Owner
Bought 61,516 sh at $17.00 · Sep 28, 2026
$1M
FilingGordon Carl LDirector · 10% Owner
Bought 61,516 sh at $17.00 · Sep 28, 2026
$1M
FilingChimovits ErezDirector
Bought 61,516 sh at $17.00 · Sep 28, 2026
$1M
FilingGeorge SimeonDirector · 10% Owner
Bought 592,593 sh at $17.00 · Sep 28, 2026
$10.1M
FilingSr One Capital Management, LLC10% Owner
Bought 592,593 sh at $17.00 · Sep 28, 2026
$10.1M
FilingGeorge SimeonDirector · 10% Owner
Bought 592,593 sh at $17.00 · Sep 28, 2026
$10.1M
FilingSr One Capital Management, LLC10% Owner
Bought 592,593 sh at $17.00 · Sep 28, 2026
$10.1M
FilingSr One Capital Management, LLC10% Owner
Bought 414,814 sh at $17.00 · Sep 28, 2026
$7.1M
FilingGeorge SimeonDirector · 10% Owner
Bought 414,814 sh at $17.00 · Sep 28, 2026
$7.1M
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
ADRX insider trading by quarter
No open-market purchase or sale by a ADARx Pharmaceuticals, Inc. insider appears in SEC's Form 4 data for trades between Jul 01, 2024 and Jun 30, 2026. Grants, option exercises, gifts and tax withholding are not counted as trades.
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check ADRX — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
ADARx Pharmaceuticals, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are ADRX insiders buying or selling?
- Between Sep 28, 2026 and Sep 28, 2026, 5 ADARx Pharmaceuticals, Inc. insiders made 13 open-market purchases worth $87.7M and no sales, a net purchase of $87.7M.
- How much ADRX stock have insiders bought and sold in the last two years?
- None on the open market: no purchase or sale by a ADARx Pharmaceuticals, Inc. insider appears in SEC's Form 4 data for trades between Jul 01, 2024 and Jun 30, 2026. Grants, option exercises, gifts and tax withholding are not counted as trades.
- What was the largest recent ADRX insider trade?
- George Simeon (Director · 10% Owner) bought $10.1M of ADRX stock on Sep 28, 2026 at about $17.00 a share.
- When did an insider last buy ADRX shares?
- The most recent open-market purchase on file is Gordon Carl L (Director · 10% Owner) buying $10M on Sep 28, 2026. The largest purchase in the period was $10.1M by George Simeon.
- Where does ADRX insider trading data come from?
- From the Form 4 filings ADARx Pharmaceuticals, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.